Ophthalmology · Buena Park, CA
NPI
1255431300
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
5832 Beach Blvd Unit 109a
Buena Park, CA, 90621
Phone (714) 228-1888
Groups this clinician bills Medicare through
Medicare paid, 2024
$457K
6,719 services
Medicare patients, 2024
799
Average age 79
Drug cost, 2024
$4.7M
14,141 prescriptions
Company payments, 2025
$1,599
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yun J Kim was code 92014 (ophthalmological e&m), 1,346 times for 684 patients. In total Yun J Kim billed 6,719 services in 27 codes, and Medicare paid $457K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 1,346 | 684 | $99.79 | $134K |
| 68761 Eye | Office | 1,171 | 585 | $115.60 | $135K |
| 92250 Angiography | Office | 627 | 615 | $28.57 | $18K |
| 92083 Vision, Hearing, and Speech Services | Office | 532 | 515 | $50.56 | $27K |
| 92020 Ophthalmological E&M | Office | 531 | 516 | $21.27 | $11K |
| 92133 Computerized Ophthalmic Imaging | Office | 518 | 503 | $26.84 | $14K |
| 92134 Computerized Ophthalmic Imaging | Office | 460 | 434 | $31.86 | $15K |
| 99214 Office E&M - Established | Office | 296 | 255 | $100.12 | $30K |
| 76514 Ultrasound - Nonspecific | Office | 166 | 163 | $7.99 | $1,326 |
| 99204 Office E&M - New | Office | 162 | 162 | $125.20 | $20K |
| 92136 Ultrasound - Nonspecific | Office | 156 | 144 | $35.03 | $5,465 |
| 67820 Eye | Office | 146 | 132 | $13.19 | $1,926 |
| 92201 Ophthalmological E&M | Office | 135 | 128 | $19.22 | $2,594 |
| 92012 Ophthalmological E&M | Office | 124 | 100 | $71.93 | $8,919 |
| 83861 Clinical Chemistry | Office | 106 | 52 | $22.03 | $2,335 |
By year: 2022 $466K for 7,013 services; 2023 $502K for 7,551 services; 2024 $457K for 6,719 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 106 | 52 | $22.03 | $2,335 |
Medicare prescription drug claims, 2024
In 2024, the drug Yun J Kim prescribed most often to Medicare patients was Restasis (Cyclosporine), with 2,822 prescriptions and refills. In total Yun J Kim wrote 14,141 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 2,822 | 3,121 | 692 | $1.9M |
| Xiidra Lifitegrast | 1,838 | 2,017 | 590 | $1.4M |
| Cyclosporine Generic | 1,486 | 1,844 | 492 | $494K |
| Azelastine Hcl Generic | 1,396 | 1,601 | 389 | $16K |
| Latanoprost Generic | 1,102 | 1,493 | 270 | $7,320 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 863 | 1,481 | 260 | $14K |
| Brimonidine Tartrate Generic | 613 | 817 | 148 | $39K |
| Zerviate Cetirizine Hcl | 392 | 466 | 116 | $171K |
| Alphagan P Brimonidine Tartrate | 363 | 411 | 85 | $85K |
| Prednisolone Acetate Generic | 319 | 357 | 209 | $11K |
| Simbrinza Brinzolamide/Brimonidine Tart | 289 | 402 | 78 | $63K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 241 | 254 | 210 | $2,520 |
| Vyzulta Latanoprostene Bunod | 186 | 218 | 46 | $58K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 171 | 209 | 40 | $15K |
| Tobradex Tobramycin/Dexamethasone | 159 | 159 | 137 | $42K |
Brand drugs: 8,921 claims; generic drugs: 5,220 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yun J Kim $1,599 ($1,599 in general payments such as food, travel and fees) from 10 companies. The largest payer was Bausch & Lomb Americas Inc. with $741.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 26 | $741 |
| Alcon Vision LLC ALC | 12 | $286 |
| Carl Zeiss Meditec USA, Inc. | 3 | $165 |
| Astellas Pharma US Inc 4503.T | 1 | $134 |
| Amgen Inc. AMGN | 3 | $88.25 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $52.85 |
| Abbvie Inc. ABBV | 2 | $38.11 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $35.47 |
| Oyster Point Pharma, Inc. | 2 | $30.48 |
| Dompe US, Inc. | 1 | $27.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.